Intervention

Samotolisib

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 2 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials2
Recruiting0
Common conditions25
Lead sponsors shown1
Advertisement

Clinical trials

2 shown
Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)NCT03213678 · 2017-11-28
COMPLETED
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)NCT03155620 · 2017-07-31
ACTIVE_NOT_RECRUITING

Common conditions

Advanced Malignant Solid Neoplasm2Ann Arbor Stage III Non-Hodgkin Lymphoma2Ann Arbor Stage IV Non-Hodgkin Lymphoma2Malignant Glioma2Recurrent Ependymoma2Recurrent Ewing Sarcoma2Recurrent Glioma2Recurrent Hepatoblastoma2Recurrent Langerhans Cell Histiocytosis2Recurrent Malignant Germ Cell Tumor2Recurrent Malignant Solid Neoplasm2Recurrent Medulloblastoma2Recurrent Neuroblastoma2Recurrent Non-Hodgkin Lymphoma2Recurrent Osteosarcoma2Recurrent Peripheral Primitive Neuroectodermal Tumor2Recurrent Primary Central Nervous System Neoplasm2Recurrent Soft Tissue Sarcoma2Refractory Langerhans Cell Histiocytosis2Refractory Malignant Germ Cell Tumor2Refractory Malignant Solid Neoplasm2Refractory Neuroblastoma2Refractory Non-Hodgkin Lymphoma2Refractory Primary Central Nervous System Neoplasm2Rhabdoid Tumor2

Trial status mix

ACTIVE_NOT_RECRUITING1
COMPLETED1

Phase mix

PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.